跳至主要内容
临床试验/NCT06480617
NCT06480617进行中(未招募)不适用

The First Affiliated Hospital of USTC (Anhui Provincial Hospital)

Anhui Provincial Hospital1 个研究点 分布在 1 个国家目标入组 3,000 人开始时间: 2023年10月31日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
3,000
试验地点
1
主要终点
progression-free survival

研究概览

简要总结

This is a large non-interventional observational bidirectional study planned to collect clinically relevant data and prognostic follow-up information of patients with cervical cancer who were seen at our center from 2010.01.01 to the end of this study.

详细描述

This study is a large-scale observational, bi-directional analytical study, which collects clinical data from patients with cervical cancer who have received treatment in the Department of Gynecologic Oncology of the First Hospital Affiliated to the University of Science and Technology of China (Anhui Provincial Hospital), including age, weight, BMI, menopausal status, history of the current disease, past history, specialized examinations, results of tests, results of genetic testing, pathology-related data, and information related to surgery, etc. The diagnosis, subsequent treatment, and follow-up of the subjects follow the routine clinical procedures of the clinical center. The diagnosis and subsequent treatment and follow-up of the subjects followed the routine clinical procedures of the clinical center, and the follow-up data of the enrolled patients were collected every six months: imaging, tumor markers, recurrence and treatment. And clinical big data analysis. Therefore, patients who meet the enrollment criteria can be included, and the sample size is based on the actual number of cases included.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age ≥ 18 years;
  • patients with a clear pathological diagnosis of cervical cancer;
  • all patients included in this study were diagnosed after 1 January 2010
  • Diagnosis or treatment of cervical cancer at the centres covered by this study;
  • exemption from informed consent or signing of an informed consent form.

排除标准

  • Loss of contact during the follow-up period for no apparent reason;
  • Discharged from the hospital for follow-up treatment at an outside institution with unknown treatment status;
  • The investigator considers the patient unsuitable for participation in this study;
  • cases where the clinical diagnosis is in doubt or unclear.

结局指标

主要结局

progression-free survival

时间窗: 5 years

次要结局

  • overall survival(5 years)

研究者

发起方
Anhui Provincial Hospital
申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验